Many thanks for your interest in the Recall Pilot Study. This study is now closed. We will update this website with further information as it becomes available.

What is the RECALL study?

You may have received a letter from your GP informing you about this study.

The RECALLpilot study was designed to determine the feasibility of a prospective, randomised, double-blind clinical trial of reducing systolic blood pressure to prevent dementia and cognitive decline.

Dementia is one of the biggest health and social care challenges of the 21st century. Unfortunately, there is no cure for the most common types of dementia. However, latest research suggests we can protect our brains by controlling our blood pressure, and there is growing evidence that dementia can be prevented in this way.

We plan to conduct a large online study to test whether giving people medication to lower blood pressure reduces their risk of developing dementia. Before we do this, we want to check that the various parts of the study will work when used by participants and healthcare professionals in the real world. This RECALL pilot study aims to test whether the final study will work, or if we need to make changes to ensure that taking part is straightforward. There are two parts to the pilot study:

Part one involves registering for the study, providing consent, and entering personal and medical details into a secure personal account via this website. You will also be asked to complete some cognitive (brain) function games to assess your thinking and memory.

Part two involves visiting your GP practice, MEMO Research at Ninewells Hospital, or community hub (or similar facility) for a blood test. We will also give you a blood pressure monitor so that you can measure your blood pressure at home and enter the results into your account via the study website.

A short video summarising this pilot study is also available to view by clicking below.

You may view the Patient Information Sheet that details all aspects of the study by clicking here. View Patient Information Sheet.

If you would like to know more about the RECALL pilot study, please fill in the Contact Us form below, or call the RECALL team on 0800 9173509.

Frequently Asked Questions

I don’t have a computer. Can I still take part?

Yes. You can take part in this study using a library or friend’s computer, or a smart phone.

I am taking part in another study. Can I do this one too?

We are happy for you to take part in other trials whilst completing this pilot study. However, we advise that you consult the other research team beforehand, to make sure they agree. It may be useful to inform them that this pilot study does not involve you taking any medication.

Does my GP practice know about this?

This work is fully supported by your GP Practice. We are trying to minimise the workload on your GP surgery so would prefer it if you contacted us with any questions about the pilot study, but please feel free to discuss with your practice if you prefer.

How do I know my personal and medical data will be safe?

Identifiable information about you and the information collected about you during the study will be stored securely on password protected database(s) by MEMO Research, University of Dundee. Only specified members of the research team will have access to this information. Information which identifies you will not be published or shared.
We will only use your personal information to carry out this study or contact you again if you have agreed to this.
The University of Dundee and NHS Tayside are the sponsors for this study based in the United Kingdom. We will be using information from you in order to undertake this study and will act as the data controller for this study. This means that we are responsible for looking after your information and using it properly.
Further information on this topic is outlined in the patient information leaflet, a link to which will provided before you give consent to take part in this trial.

I don’t have dementia, can I still take part?

Yes. We are looking for people who do not have dementia to take part in the RECALL study. Your involvement would be valuable to the study.

What happens if I am diagnosed with dementia?

The tests in the RECALL pilot study are not able to diagnose dementia as they are a small set of isolated tests. If you are concerned about your thinking or memory, please discuss this with your GP.

Does the RECALL pilot study involve taking any medicines?

No, this initial pilot study does not involve taking any medicines.

Do I need to change any of my existing medicines?

No. You should continue taking any usual medications as prescribed.

Need to get in touch?

By Post

RECALL study,
MEMO Research, Level 7,
Ninewells Hospital and Medical School,
Dundee, UK,


By Phone

01382 383119
Monday to Friday
8.45am to 5.00pm


By Email
Or click here to use our contact form


For more detailed information about dementia and high blood pressure, please click the links below. On these pages, you will find additional information and links to other peer reviewed papers covering this research area.

University of Dundee Logo
Memo Research Logo
Recall Logo

The Team
Here to help you

Dr Evelien Rooke

Clinical Reseach Fellow and Senior Neurology Registrar Doctor. Particular interests include neurocognitive disorders and medical education.

Dr Greg Guthrie

Clinical Research Fellow and Specialty Trainee in Nephrology and General Medicine. Interests in chronic kidney disease, inequality and rational study design.

Dr Amy Rogers

Clinical Research Fellow focusing on large scale drug safety and effectiveness trials. Particular interests include pragmatic research methodologies and evidence based prescribing in primary care.

Caroline Hall

Lead Clinical Trials Nurse with extensive clinical research experience in large, randomised, long-term multi-centre studies. Particular interests include trial recruitment and retention and improving participant’s experience of trials.

Kris Zutis

Lead RECALL study developer at MEMO Research. Main research interests include enhancing digital clinical trials as well as the application of machine learning techniques for advancing medical research.

Lewis McConnachie

IT manager for MEMO Research. Focusing on improving clinical technlogy in healthcare for the public and medical professionals.

David Rorie

Senior software developer at MEMO Research with a background in large scale online clinical trials.